Galmed Pharmaceuticals
Galmed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for liver diseases. Its lead compound, Aramchol™, is currently in Phase III trials for the treatment of non-alcoholic steato-hepatitis (NASH) and fibrosis.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
1 past transactions
OnKai
Corporate Round in 2023
OnKai is an AI-based platform focused on enhancing healthcare accessibility and quality for local health care professionals. The company aims to address unmet patient needs by connecting healthcare providers with foundations and service organizations. Through its innovative technology, OnKai facilitates improved collaboration among stakeholders, ultimately striving to achieve better health outcomes for communities. The platform is designed to ensure that individuals have access to high-quality and affordable healthcare services, thereby promoting equity in healthcare delivery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.